e-learning
resources
Virtual 2020
Pre-Congress Content
Clinical issues in granulomatous lung diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Relapse ratios and factors affecting relapse in sarcoidosis patients that are followed at least 5 years.
n. orhan ozer (istanbul, Turkey), E. Niksarlioglu (istanbul, Turkey), E. Altundas Hatman (istanbul, Turkey), A. Yeter (istanbul, Turkey), E. Sahin (istanbul, Turkey), G. Çamsari (istanbul, Turkey)
Source:
Virtual Congress 2020 – Clinical issues in granulomatous lung diseases
Session:
Clinical issues in granulomatous lung diseases
Session type:
E-poster session
Number:
3007
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
n. orhan ozer (istanbul, Turkey), E. Niksarlioglu (istanbul, Turkey), E. Altundas Hatman (istanbul, Turkey), A. Yeter (istanbul, Turkey), E. Sahin (istanbul, Turkey), G. Çamsari (istanbul, Turkey). Relapse ratios and factors affecting relapse in sarcoidosis patients that are followed at least 5 years.. 3007
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Late Breaking Abstract - Efficacy of Breathox® device inhalation on acute symptoms associated with COVID-19 (BREATH study)
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
The effectiveness of plasmaferesis in patients with relapsing and progressing course of pulmonary sarcoidosis (5 years follow-up)
Source: Annual Congress 2010 - Clinical issues in diffuse parenchymal lung disease
Year: 2010
Childhood factors associated with complete and clinical asthma remission at 25 and 49 years
Source: Eur Respir J, 49 (6) 1601974; 10.1183/13993003.01974-2016
Year: 2017
The analysis of lung cancer patients (LCP) survival during 5 year period after diagnosis of disease
Source: Eur Respir J 2006; 28: Suppl. 50, 88s
Year: 2006
Treatment outcome and risk factors of death in elderly patients diagnosed as new cases of tuberculosis
Source: Annual Congress 2010 - Prognosis of tuberculosis
Year: 2010
TB re-treatment results in relapses, default and failure – cohort study for 7 years
Source: Annual Congress 2006 - Clinical epidemiology of tuberculosis
Year: 2006
Asthma; gender differences in incidence and remission from 10 to 16 years?
Source: Annual Congress 2010 - Risk factors for allergic diseases in children
Year: 2010
Study of risk factors in relapses at patients with pulmonary tuberculosis. Their retreatment results
Source: Eur Respir J 2001; 18: Suppl. 33, 467s
Year: 2001
Prognosis in chronic cough at 3 and 6 monts of follow-up according the presence of aggravating factors
Source: Annual Congress 2009 - Pleural and parenchymal diseases
Year: 2009
Different mortality, recurrence and bleeding between cancer and non cancer patients with pulmonary embolism (PE): 1 year follow-up.
Source: International Congress 2017 – Prognostic factors and outcomes in pulmonary embolism
Year: 2017
Analysis of cases from an interstitial lung disease (ILD) MDT in a teaching hospital in the West Midlands: Patients with smoking-related disease comprise 11% of cases and have a median age of 50 years
Source: Annual Congress 2012 - Diffuse parenchymal lung disease III
Year: 2012
Prevalence of heart disease in patients hospitalized for an acute exacerbation of COPD: Impact on clinical outcome. A 6 month follow-up study
Source: Annual Congress 2011 - COPD management
Year: 2011
Patterns of drug resistance at initiation of re-treatment across relapse, default and failure subcategories in previously treated tubercular patients
Source: Annual Congress 2011 - Epidemiology of multidrug-resistant and extensively drug-resistant tuberculosis
Year: 2011
Risk factors associated with treatment interruption for 2 months among tuberculosis patients in Taipei
Source: Annual Congress 2007 - Tuberculosis control
Year: 2007
Factors affecting the duration from diagnosis to treatment in patients with lung cancer
Source: Eur Respir J 2007; 30: Suppl. 51, 668s
Year: 2007
Early lower airway infection: risk factors for asthma at age of 14-16 years
Source: Eur Respir J 2004; 24: Suppl. 48, 717s
Year: 2004
The risk of tuberculosis disease among HIV infected patients after 2 years of follow up
Source: Annual Congress 2011 - Tuberculosis in immunocompromised hosts
Year: 2011
The influence of metabolic syndrome in mortality rate of COPD patients: A five years follow up study
Source: Annual Congress 2012 - COPD comorbidities II
Year: 2012
Pathophysiological risk factors for chronization of bronchitis in children aged 7-10 years
Source: Annual Congress 2008 - Infectious lung diseases including tuberculosis
Year: 2008
Predicted factors of radiographic sequelae in tuberculosis treated patients.
Source: International Congress 2019 – Tuberculosis: diagnosis
Year: 2019
One-year survival in patients hospitalized due to an acute exacerbation of COPD. Related factors
Source: Annual Congress 2009 - COPD: exacerbation and clinical problems
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept